Reading list PG6 Lung fibrosis and sarcoidosis


Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Session: PG6 Lung fibrosis and sarcoidosis
Session type: Postgraduate Course
Number: 27002
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Reading list PG6 Lung fibrosis and sarcoidosis. International Congress 2016 – PG6 Lung fibrosis and sarcoidosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Programme PG6 Lung fibrosis and sarcoidosis
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016

Reading list CC2 Children’s interstitial lung disease
Source: International Congress 2016 – CC2 Children’s interstitial lung disease
Year: 2016

Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
Source: International Congress 2014 – ILDs 4
Year: 2014

Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
Source: International Congress 2014 – ILDs 4
Year: 2014


Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010


Reading list LPE Lung cancer
Source: Amsterdam 2015 - Educational material
Year: 2015

Lung function of idiopathic pulmonary fibrosis: Russian IPF registry (Moscow region)
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 3
Year: 2014


Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014


6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014


Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014


Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Six-minute walk test desaturation and echocardiographic findings in IPF: Correlational observations made in the European IPF registry (eurIPFreg)
Source: International Congress 2014 – ILDs 2
Year: 2014

The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014


Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO
Source: International Congress 2014 – ILDs 6
Year: 2014


Reading list LPE Interstitial and pleural diseases
Source: Amsterdam 2015 - Educational material
Year: 2015

Evolution of an interstitial lung disease MDT: 5.5 years of data
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014